Who owns Attovia Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ATTO from SEC Form 13F filings across 64 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 64 institutions disclosed 40.1M shares of Attovia Therapeutics, Inc. worth $686.7M — about 136.4% of shares outstanding; the largest disclosed holder is Frazier Life Sciences Management, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
64
13F holders
$686.7M
value, 2026 filers
136.4%
of shares outstanding (40.1M sh)
64
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ATTO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Frazier Life Sciences Management, L.P.NEW | 7.0M | $120.8M | 3.0% | 24% | new |
| 2 | GOLDMAN SACHS GROUP INCNEW | 5.4M | $92.4M | 0.0% | 18.4% | new |
| 3 | venBio Partners LLCNEW | 4.2M | $71.7M | 14.5% | 14.2% | new |
| 4 | Deep Track Capital, LPNEW | 3.2M | $55.0M | 0.9% | 10.9% | new |
| 5 | EcoR1 Capital, LLCNEW | 2.0M | $34.7M | 1.5% | 6.9% | new |
| 6 | Nextech Invest Ltd.NEW | 1.8M | $31.5M | 1.4% | 6.2% | new |
| 7 | Cormorant Asset Management, LPNEW | 1.8M | $30.7M | 2.1% | 6.1% | new |
| 8 | Redmile Group, LLCNEW | 1.2M | $19.9M | 1.5% | 4% | new |
| 9 | Commodore Capital LPNEW | 1.2M | $19.9M | 1.5% | 3.9% | new |
| 10 | SanofiNEW | 1.1M | $18.6M | 2.9% | 3.7% | new |
| 11 | Janus Henderson Group Ltd.NEW | 1.0M | $17.1M | 0.0% | 3.4% | new |
| 12 | MARSHALL WACE, LLPNEW | 898,980 | $15.4M | 0.0% | 3.1% | new |
| 13 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 782,012 | $13.4M | 0.0% | 2.7% | new |
| 14 | FEDERATED HERMES, INC.NEW | 700,000 | $12.0M | 0.0% | 2.4% | new |
| 15 | Woodline Partners LPNEW | 686,746 | $11.8M | 0.0% | 2.3% | new |
| 16 | Nantahala Capital Management, LLCNEW | 561,180 | $9.6M | 0.3% | 1.9% | new |
| 17 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 500,000 | $8.6M | 0.0% | 1.7% | new |
| 18 | MILLENNIUM MANAGEMENT LLCNEW | 476,261 | $8.2M | 0.0% | 1.6% | new |
| 19 | CITADEL ADVISORS LLCNEW | 466,773 | $8.0M | 0.0% | 1.6% | new |
| 20 | Balyasny Asset Management L.P.NEW | 459,297 | $7.9M | 0.0% | 1.6% | new |
| 21 | Integral Health Asset Management, LLCNEW | 450,000 | $7.7M | 0.5% | 1.5% | new |
| 22 | Blackstone Inc.NEW | 339,920 | $5.8M | 0.0% | 1.2% | new |
| 23 | FMR LLCNEW | 323,669 | $5.5M | 0.0% | 1.1% | new |
| 24 | Vivo Capital, LLCNEW | 300,000 | $5.1M | 0.6% | 1% | new |
| 25 | BlackRock, Inc.NEW | 265,397 | $4.5M | 0.0% | 0.9% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.